Cleared Traditional

K100263 - ELITECH CLINICAL SYSTEMS PHOSPHORUS, URIC ACID MONO SL AND UREA UV SL REAGENTS

K100263 is an FDA 510(k) clearance for ELITECH CLINICAL SYSTEMS PHOSPHORUS, manufactured by Seppim S.A.S.. The device is a Class 1 Chemistry device with product code CEO cleared through the Traditional 510(k) pathway after a 463-day FDA review.

K100263 · Seppim S.A.S. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2011
Decision
463d
Days
Class 1
Risk

K100263 is an FDA 510(k) clearance for the ELITECH CLINICAL SYSTEMS PHOSPHORUS, URIC ACID MONO SL AND UREA UV SL REAGENTS. Classified as Phosphomolybdate (colorimetric), Inorganic Phosphorus (product code CEO), Class I - General Controls.

Submitted by Seppim S.A.S. (Bothell, US). The FDA issued a Cleared decision on May 6, 2011 after a review of 463 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1580 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Chemistry submissions.

View all Seppim S.A.S. devices

FDA 510(k) Submission Details - K100263

510(k) Number K100263 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 28, 2010
Decision Date May 06, 2011
Days to Decision 463 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
375d slower than avg
Panel avg: 88d · This submission: 463d
Pathway characteristics
Predicate-based equivalence.

CEO Device Classification - Class 1, General Controls

Product Code CEO Phosphomolybdate (colorimetric), Inorganic Phosphorus
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1580
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CEO Phosphomolybdate (colorimetric), Inorganic Phosphorus

All 97
Devices cleared under the same product code (CEO) and FDA review panel - the closest regulatory comparables to K100263.
S40 CLINICAL ANALYZER, S TEST IP, S TEST UA
K072141 · Alfa Wassermann Diagnostic Technologies, Inc. · Jun 2008
SYNCHRON SYSTEMS PHOSPHORUS (PHS) REAGENT
K041643 · Beckman Coulter, Inc. · Aug 2004
PICCOLO PHOSPHORUS TEST SYSTEM
K022312 · Abaxis, Inc. · Sep 2002
WIENER LAB.FOSFATEMIA UV, MODELS 1X100 ML CAT.N 1382321, 4X20 ML CAT.N 1009311
K013095 · Wiener Laboratories Saic · Nov 2001
PHOSPHORUS REAGENT
K003912 · Jas Diagnostics, Inc. · Feb 2001
RAICHEM PHOSPORUS REAGENT
K003012 · Hemagen Diagnostics, Inc. · Oct 2000